COMMUNIQUÉS West-GlobeNewswire

-
OrganOx Honoured as Winner of the 2025 MacRobert Award for UK Engineering Innovation
09/07/2025 -
TerrAscend Completes $79 Million Non-Dilutive Debt Financing
09/07/2025 -
Benitec Biopharma Provides Operational Updates
09/07/2025 -
FluidForm Bio™ Presents Six-Month Efficacy Data of FRESH 3D Bioprinted Human Islet Subcutaneous Scaffolds at the American Diabetes Association (ADA) 85th Scientific Sessions
09/07/2025 -
Galectin Therapeutics Announces New $10 Million Credit Line from Richard E. Uihlein, Sufficient to Cover Expected Expenditures Through June 2026
09/07/2025 -
Amneal to Report Second Quarter 2025 Results on August 5, 2025
09/07/2025 -
BioVie Announces Data Highlighting Bezisterim’s Potential to Slow or Reverse Biological Aging and Neurodegeneration Featured as a Keynote Talk at the 7th World Aging and Rejuvenation Conference
09/07/2025 -
Jasper Therapeutics Announces Corporate Reorganization and Other Cost Cutting Measures to Extend Cash Runway
09/07/2025 -
Dr. Anosh Ahmed Plans $25,000 Donation to Support FBI Families and Law Enforcement Mental Health Programs
09/07/2025 -
Revolution Medicines and Iambic Announce Technology and Research Collaboration Using Iambic’s AI Discovery Tools to Pursue New Drug Candidates
09/07/2025 -
The Anosh Foundation Launches Global Oversight Initiative to Strengthen COVID-19 Testing and Vaccination Integrity
09/07/2025 -
New Clinical Findings Published in Scientific Journal Nature Validate LIXTE’s Ongoing Ovarian and Colorectal Cancer Trials
09/07/2025 -
MaxCyte to Report Second Quarter 2025 Financial Results on August 6, 2025
09/07/2025 -
Candel Therapeutics Expands Russell Index Presence with Addition to Multiple Value-Oriented Indexes in 2025 Reconstitution
09/07/2025 -
Evoke Pharma Receives Notice of Allowance for U.S. Patent Application for GIMOTI Extending Orange Book listings to 2036
09/07/2025 -
Vireo Growth Inc. Announces Retirement of November 2024 Convertible Note
09/07/2025 -
FibroBiologics Confirms Ability to Manufacture CybroCell™ for Degenerative Disc Disease and Cartilage Repair Programs from Existing CYWC628 Master Cell Bank
09/07/2025 -
THC Therapeutics, Inc. Announces Acquisition of SugarTop Buddery
09/07/2025 -
Clover Health Launches New Jersey Community Pharmacy Program in Partnership with IPC’s iCare+ Network
09/07/2025
Pages